Sunshine Biopharma, Inc (44)
Browse by Contract Category
Contracts
-
Form of Pre-Funded Warrant
(Filed With SEC on May 16, 2023)
-
Form of Registration Rights Agreement
(Filed With SEC on May 16, 2023)
-
Form of Warrant
(Filed With SEC on May 16, 2023)
-
Form of Securities Purchase Agreement
(Filed With SEC on May 16, 2023)
-
Placement Agent Agreement dated May 12, 2023
(Filed With SEC on May 16, 2023)
-
The License Agreement between the Company and the University of Arizona
(Filed With SEC on February 28, 2023)
-
Research Agreement between the Company and JGH
(Filed With SEC on February 10, 2023)
-
Employment Agreement between Sunshine Biopharma, Inc., Nora Pharma Inc. and Malek Chamoun
(Filed With SEC on October 20, 2022)
-
Share Purchase Agreement between Sunshine Biopharma, Inc., Malek Chamoun and Nora Pharma Inc
(Filed With SEC on October 20, 2022)
-
Form of Warrant
(Filed With SEC on April 28, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on April 28, 2022)
-
Form of Registration Rights Agreement
(Filed With SEC on April 28, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on April 28, 2022)
-
Engagement Letter dated April 25, 2022
(Filed With SEC on April 28, 2022)
-
Employment Agreement between Sunshine Biopharma, Inc. and Dr. Steve Slilaty
(Filed With SEC on April 8, 2022)
-
Description of Registrants Securities
(Filed With SEC on March 21, 2022)
-
Form of Warrant
(Filed With SEC on March 15, 2022)
-
Form of Registration Rights Agreement
(Filed With SEC on March 15, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on March 15, 2022)
-
Engagement Letter dated March 9, 2022, as amended
(Filed With SEC on March 15, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on March 15, 2022)
-
Research Agreement, dated February 18, 2022, between the Company and the University
(Filed With SEC on February 25, 2022)
-
Warrant Agency Agreement between Sunshine Biopharma, Inc. and Equiniti Trust Company, dated February 17, 2022
(Filed With SEC on February 17, 2022)
-
Underwriting Agreement between Sunshine Biopharma, Inc. and Aegis Capital Corp., dated February 15, 2022
(Filed With SEC on February 17, 2022)
-
Form of Warrant
(Filed With SEC on February 17, 2022)
-
Form of Warrant for offering
(Filed With SEC on February 14, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on February 14, 2022)
-
Form of Warrant Agent Agreement
(Filed With SEC on February 9, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on February 9, 2022)
-
Form of Warrant for offering
(Filed With SEC on February 9, 2022)
-
Form of Pre-Funded Warrant for offering
(Filed With SEC on February 9, 2022)
-
Sponsored Research Agreement, dated October 6, 2020, between the Company and the University of Georgia Research Foundation, Inc
(Filed With SEC on January 24, 2022)
-
Financing Agreement with RB Capital Partners, Inc
(Filed With SEC on September 15, 2020)
-
Share Transfer Agreement with Atlas Pharma Inc., et al
(Filed With SEC on July 19, 2019)
-
Registration Rights Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC
(Filed With SEC on September 14, 2018)
-
Equity Financing Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC
(Filed With SEC on September 14, 2018)
-
Promissory Note issued by Sunshine Biopharma, Inc. in favor of GHS Investments LLC
(Filed With SEC on September 14, 2018)
-
AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of March 14, 2016
(Filed With SEC on March 14, 2016)
-
AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of March 14, 2016
(Filed With SEC on March 14, 2016)
-
Patent Purchase Agreement with Advanomics Corporation
(Filed With SEC on December 28, 2015)
-
PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of October 8, 2015 PATENT PURCHASE AGREEMENT
(Filed With SEC on October 9, 2015)
-
INVESTMENT AGREEMENT
(Filed With SEC on April 28, 2014)
-
REGISTRATION RIGHTS AGREEMENT
(Filed With SEC on April 28, 2014)
-
AMENDMENT 2 TO EXCLUSIVE LICENSE AGREEMENT
(Filed With SEC on December 27, 2011)